Company | PNC Financial Services Group |
Ticker | PNC |
Upcoming Earnings Date | ~July 15, 2026 (Q2 2026) |
Prepared Date | July 14, 2026 |
Reporting Period | Q2 2026 (April 1 – June 30, 2026) |
Key Takeaway: The setup is constructive — PNC guided to the high end of its Q2 ranges at the Morgan Stanley conference in June, NIM is on track to cross 3% ahead of schedule, and the FirstBank conversion is complete, but the stock has already rallied ~13% since Q1 earnings, leaving limited room for upside surprise.
Heading into Q2 2026 earnings, the bar for PNC is moderately high but achievable: consensus sits at NII of ~$4.09B and adj. EPS of ~$4.59, both of which management effectively pre-confirmed at the June 9 Morgan Stanley conference when — with roughly two-thirds of the quarter complete — they stated the company was tracking to the high end of its Q2 NII and fee guidance ranges. Management's tone has been consistently constructive since Q1 earnings, with the June conference adding a notable positive surprise: a ~$400M Visa B share exchange gain above original guidance, which inflates the headline fee income number but is well-understood by the Street. Estimate revisions have moved modestly higher since Q1 earnings, tracking guidance rather than diverging from it, which means there is limited cushion from a low bar but also limited risk of a guidance-driven miss. The stock has outperformed meaningfully — up +13.4% since Q1 earnings vs. KRE +8.4% and SPY +7.4% — suggesting the market has already priced in a solid print, and the multiple has re-rated as the FirstBank integration de-risked with the June 22 systems conversion completion. The key wildcard is whether the Visa B gain and FirstBank revenue synergies can drive a genuine upside surprise beyond the pre-guided high end, while NFI/private credit exposure and any deposit mix shift pressure on NIM remain the primary downside watch items.
Key Takeaway: Consensus is a moderate bar — NII and NIM are the primary swing factors, with management having already guided to the high end of Q2 ranges; fee income and credit quality are secondary but important watch items.
KPI | Q1 2026 Actual | Q2 2025 Actual | Q2 2026 Consensus | YoY Change | Q2 Guidance | Cons vs. Guidance |
Net Interest Income | $3.961B | $3.555B | $4.092B | +15.1% | ~$4.08B (up ~3% QoQ) | +0.3% |
Net Interest Margin | 2.95% | 2.80% | 2.99% | +19 bps | Above 3% in 2H | On track |
Total Noninterest Income (Fee) | $2.204B | $2.106B | $2.455B | +16.6% | Up ~2.5% QoQ (~$2.26B) | +8.6% (incl. Visa B ~$400M) |
Adj. EPS (Operating) | $4.32 | $3.85 | $4.59 | +19.2% | N/A | N/A |
Provision for Credit Losses | $210M | $254M | $241M | -5.1% | NCOs ~$225M | In line |
Net Charge-Off Ratio | 0.29% | 0.25% | 0.25% | flat | ~$225M NCOs | In line |
Operating Expenses (ex-integration) | $3.671B | $3.383B | $3.751B | +10.9% | Up ~2% QoQ (~$3.74B) | +0.3% |
Efficiency Ratio | 61.1% | 59.8% | 60.1% | +30 bps | N/A | N/A |
ROTCE | 15.2% | 15.2% | 16.1% | +90 bps | ~18% by Q4 2026 | Tracking |
CET1 Ratio | 10.09% | 10.52% | 10.16% | -36 bps | N/A | N/A |
Total Loans | $360.9B | $326.3B | $363.8B | +11.5% | Up 2–3% QoQ | In line |
Total Deposits | $457.6B | $426.7B | $460.9B | +8.0% | N/A | N/A |
Source: Visible Alpha Consensus and Actuals Data. Note: The fee income consensus of $2.455B likely embeds the Visa B share gain of ~$400M (above guidance), which management disclosed at the June Morgan Stanley conference. Excluding this, core fee income consensus would be ~$2.05B, roughly in line with guidance of up ~2.5% QoQ.
Quarter | NII Reported | NII Consensus | NII Surprise | NII Result | Adj. EPS Reported | Adj. EPS Consensus | EPS Surprise | EPS Result |
Q2 2024 | $3.302B | $3.233B | +2.1% | Beat | $3.30 | $3.18 | +3.6% | Beat |
Q3 2024 | $3.410B | $3.366B | +1.3% | Beat | $3.49 | $3.29 | +6.1% | Beat |
Q4 2024 | $3.523B | $3.473B | +1.4% | Beat | $3.82 | $3.30 | +15.8% | Beat |
Q1 2025 | $3.476B | $3.444B | +0.9% | Beat | $3.51 | $3.38 | +3.8% | Beat |
Q2 2025 | $3.555B | $3.547B | +0.2% | Beat | $3.85 | $3.53 | +9.1% | Beat |
Q3 2025 | $3.648B | $3.657B | -0.2% | Miss | $4.35 | $4.05 | +7.4% | Beat |
Q4 2025 | $3.731B | $3.705B | +0.7% | Beat | $4.88 | $4.23 | +15.4% | Beat |
Q1 2026 | $3.961B | $3.963B | -0.1% | In Line | $4.32 | $4.21 | +2.5% | Beat |
Source: Visible Alpha Consensus and Actuals Data. Pattern: PNC has beaten adj. EPS consensus in all 8 of the last 8 quarters, with NII beats in 7 of 8; the consistent beat pattern has likely raised the bar heading into Q2 2026.
Key Takeaway: Management guided to the high end of Q2 NII and fee ranges at the June Morgan Stanley conference (~2/3 through Q2), and disclosed a ~$400M Visa B share gain above guidance; full-year guidance was held unchanged pending the July earnings call.
Metric | Initial Guidance (Q1 2026 Earnings, Apr 15) | Revised Guidance | Current Consensus | Note |
Q2 NII | Up ~3% QoQ (~$4.08B) | Tracking to high end of range | $4.092B | Raised at MS Conference Jun 9; constructive tone |
Q2 Fee Income | Up ~2.5% QoQ (~$2.26B) | Tracking to high end + Visa B ~$400M | $2.455B | Visa B gain above guidance disclosed Jun 9 |
Q2 Net Charge-Offs | ~$225M | Unchanged; on track | ~$241M provision | Credit on track per Jun 9 update |
FY2026 NII | Up ~14.5% YoY | Unchanged (held for July call) | $16.539B | Management awaiting 2H visibility |
FY2026 Loan Growth | Up ~11% YoY | Unchanged | $368.5B avg | FirstBank conversion complete Jun 22 |
FY2026 Fee Income | Up ~6% YoY | Unchanged | $9.354B | Visa B gain incremental upside |
FY2026 Expenses (ex-integration) | Up ~7% YoY | Unchanged | $14.846B | $350M CIP savings target intact |
NIM | Above 3% in 2H 2026 | On track; Q1 was 2.95% | 2.99% Q2 cons | Fixed-rate repricing driving expansion |
ROTCE | ~18% by Q4 2026 | Unchanged | 16.1% Q2 cons | Trajectory intact; drifting higher into 2027 |
Key Takeaway: Estimates for Q2 2026 NII and adj. EPS have risen modestly since Q1 earnings, tracking management's constructive intra-quarter update; the Visa B gain creates a one-time fee income beat that inflates the headline but is well-understood by the Street.
KPI | Period | Estimate ~Apr 22 (5d post Q1 earnings) | Current Consensus | Estimate Delta | Initial Guidance | Current Guidance | Guidance Delta | Cons vs. Guidance |
Net Interest Income | Q2 2026 | $4.081B | $4.092B | +0.3% | ~$4.08B | High end of range | Positive | +0.3% |
Net Interest Income | FY2026 | N/A | $16.539B | N/A | Up ~14.5% YoY | Unchanged | Flat | In line |
Adj. EPS (Operating) | Q2 2026 | $4.545 | $4.586 | +0.9% | N/A | N/A | N/A | N/A |
Adj. EPS (Operating) | FY2026 | N/A | $19.019 | N/A | N/A | N/A | N/A | N/A |
Total Noninterest Income | Q2 2026 | $2.308B | $2.455B | +6.4% | ~$2.26B | High end + Visa B ~$400M | Positive | +8.6% |
Total Noninterest Income | FY2026 | N/A | $9.354B | N/A | Up ~6% YoY | Unchanged | Flat | In line |
Source: Visible Alpha Consensus and Actuals Data. Note: The Q2 fee income estimate jump of +6.4% since Q1 earnings is largely explained by the Visa B share gain (~$400M) disclosed at the June Morgan Stanley conference. Core fee income estimates are broadly in line with original guidance.
Key Takeaway: PNC has outperformed both KRE and the S&P 500 since Q1 earnings (+13.4% vs. KRE +8.4% and SPY +7.4%), driven by estimate revisions higher and multiple re-rating as the FirstBank integration de-risked.
PNC vs. KRE vs. SPY — Indexed Price Performance Since Q1 2026 Earnings (Apr 15, 2026). Source: Yahoo Finance.
PNC's outperformance vs. KRE accelerated in June, coinciding with the Morgan Stanley conference constructive intra-quarter update and the June 22 FirstBank conversion completion. The stock's re-rating from a discount to peers toward fair value reflects the market's growing confidence in the NII/NIM trajectory and the integration execution. With the stock up ~13% since Q1 earnings, some of the good news is priced in, and the Q2 print will need to deliver on the high-end guidance to sustain the premium.
Key Takeaway: The most important development since Q1 earnings is the June 22 FirstBank customer and branch conversion completion — this removes the largest integration execution risk and unlocks the full revenue synergy opportunity.
Key Takeaway: Peer commentary from the June Morgan Stanley conference and today's large-cap Q2 earnings calls is broadly constructive for PNC's Q2 setup — NII tracking to guidance, fee income strong (especially capital markets), credit quality benign, and loan growth broad-based. The key watch item is deposit mix shift (DDA to interest-bearing) which could modestly pressure NIM.
Note on scope: Only commentary about Q2 2026 (the current reporting quarter) is included below. Q1 2026 earnings call commentary about Q1 results has been excluded; only forward-looking Q2 guidance and intra-quarter updates from those calls, plus today's Q2 2026 earnings calls from JPM, BAC, and WFC, are included.
Key Takeaway: No open-market buys since Q1 earnings; all transactions are discretionary open-market sales by EVPs and one director — no 10b5-1 plans disclosed. The absence of insider buying is not alarming given the stock's strong run, but the lack of any purchase signal is worth noting.
Name | Title | Transaction Type | Shares | Value (est.) | Transaction Date | Filing Date | Note |
Andrew T. Feldstein | Director | Open Market Sale | 23,000 | ~$5.1M | May 26, 2026 | May 28, 2026 | Indirect (Revocable Trust); largest sale in period |
Stephanie Novosel | EVP | Open Market Sale | 1,800 | ~$0.4M | Jun 5, 2026 | Jun 8, 2026 | Discretionary; small relative to holdings |
Alexander E.C. Overstrom | EVP | Open Market Sale | 1,500 | ~$0.35M | Jun 8, 2026 | Jun 10, 2026 | Discretionary; small relative to holdings |
Thomas Michael Duane | EVP | Open Market Sale | 1,500 | ~$0.35M | Jun 12, 2026 | Jun 16, 2026 | Discretionary; small relative to holdings |
Source: SEC Form 4 Filings. Note: No 10b5-1 plans were disclosed for any of these transactions. The EVP sales are small relative to their holdings and are consistent with routine portfolio management. The director sale (Feldstein, 23,000 shares via revocable trust) is the most notable in size but is indirect and not unusual for a director-level holder. No open-market purchases were recorded in the period.
Data Sources: Visible Alpha Consensus and Actuals Data (KPI tables, beat/miss history, estimate revisions); SEC Form 4 Filings (insider transactions); PNC Q1 2026 Earnings Call Transcript (guidance baseline); PNC Morgan Stanley US Financials Conference Transcript, Jun 9, 2026 (intra-quarter update); Peer earnings call and conference transcripts (JPM, BAC, WFC, USB, KEY, RF, FITB, TFC, HBAN, CFG, MTB); Yahoo Finance (stock price data).